InvestorsHub Logo
Followers 225
Posts 32388
Boards Moderated 3
Alias Born 10/10/2005

Re: nobodysbusiness post# 14630

Friday, 12/22/2017 9:03:30 PM

Friday, December 22, 2017 9:03:30 PM

Post# of 15274
This press release ALONE shows how inept current management is.

Note this: "Eighty percent of Calmare’s Board and its entire management team are committed to executing the Company’s strategic five-year plan to drive enhanced stockholder value. Calmare continues to pursue its strategy to grow revenue and will maintain its focus on current strategic initiatives, by gaining FDA approval for more of the Company’s devices and selling the devices to a large customer base following FDA approval.

Calmare noted that stockholders should be aware and concerned that the Minority Complaining Group is attempting to take control of Calmare’s Board and the Company without providing a detailed and credible plan as to how they would create long-term stockholder value when considering the various regulations Calmare is subject to in selling its devices."

----------------------------------------------------------------------

executing the Company’s strategic five-year plan to drive enhanced stockholder value. Does anyone here KNOW what the 5 year plan is? Why not, if there was a plan?


gaining FDA approval for more of the Company’s devices and selling the devices to a large customer base following FDA approval. WHAT other devices?!!


without providing a detailed and credible plan as to how they would create long-term stockholder value When is the management team going to provide shareholders with a "detailed and credible plan"?

The idiocy of this press release is beyond the pale.

CONRAD, PETER, --the rest of the Board! Please leave! Give the company a chance for a change.

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.